Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Intertek Group plc    ITRK   GB0031638363

INTERTEK GROUP PLC

(ITRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Intertek : Awarded Multi-Year Contract with NIOSH for Testing Post-Market N95 Respirators

10/29/2020 | 06:05am EST
Intertek Awarded Multi-Year Contract with NIOSH for Testing Post-Market N95 Respirators October 29, 2020

Cortland, N.Y. - Intertek, a Total Quality Assurance provider to industries worldwide, is pleased to announce it has won a multi-year contract with the U.S. National Institute for Occupational Safety and Health (NIOSH) for testing post-market N95 respirators. The three-year contract expands on NIOSH's existing agreement with Intertek to conduct precertification evaluations on new respirators. The Company will now assess: respirators on the market that have exceeded their original shelf life; respirators entering the United States from a foreign country and claiming to meet non-NIOSH standards; and previously used respirators that have been decontaminated and are entering the market again.

N95 respirators reduce a wearer's exposure to particles, filtering out at least 95 per cent of very small particles, including bacteria and viruses. They must be evaluated and approved by NIOSH according to requirements set forth in NIOSH 42 CFR Part 84. Under this regulation, manufacturers must submit data which illustrates compliance, including precertification tests such as inhalation/exhalation resistance, particulate filtration efficiency, and valve leakage. Intertek will conduct the precertification testing on post-market respirators, providing manufacturers with the necessary data for their NIOSH submission and approval.

Jason Allen, Technical Lead at Intertek said, 'Intertek's purpose is to bring quality and safety to life, and ensuring the quality and safety of N95 respirators has never been more important as the world continues to combat the COVID-19 pandemic. We are thrilled to use our experience in testing N95 respirators and other personal protective equipment to help NIOSH and respirator manufacturers get these essential and potentially life-saving products to market.'

Intertek provides rigorous evaluations and expansive testing capabilities to deliver assurance that, even under the most stressful or hazardous conditions, personal protective equipment will provide sustained protection. The company's industry-leading PPE testing services yield third-party test reports accepted by the Safety Equipment Institute (SEI) for a wide array of standards, assuring customers that a product meets performance and industry requirements. For more, visit: http://www.intertek.com/life-safety/ppe/.

About Intertek
Intertek is a leading Total Quality Assurance provider to industries worldwide. Our network of more than 1,000 laboratories and offices and over 46,000 people in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection, and Certification solutions for our customers' operations and supply chains. Intertek Total Quality Assurance expertise, delivered consistently with precision, pace and passion, enabling our customers to power ahead safely. www.intertek.com

For Media Information

Please contact:
Cheryl Prejsnar
Public Relations Manager
+1 630-408-5538
cheryl.prejsnar@intertek.com

Disclaimer

Intertek Group plc published this content on 29 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 October 2020 11:04:03 UTC


© Publicnow 2020
All news about INTERTEK GROUP PLC
01/20INTERTEK : certifies AGMA in Bahrain for ISO 22716 Good Manufacturing Practices
PU
01/06INTERTEK : Credit Suisse Downgrades Intertek to Neutral from Outperform, Trims P..
MT
2020INTERTEK GROUP PLC : Monthly statement on outstanding equity shares and voting r..
CO
2020INTERTEK : certified by Singapore Accreditation Council for face mask testing
PU
2020INTERTEK : SATORP achieves Intertek's Certification on Business Continuity Manag..
PU
2020INTERTEK : Appointment of a new Non-Executive Director and directorate changes
PU
2020INTERTEK GROUP PLC : Nomination
CO
2020INTERTEK : to provide Total Quality Assurance testing solutions for ASC Shipbuil..
PU
2020INTERTEK : It's good to talk – communication between labs and customers
AQ
2020INTERTEK : Appointment of a new Chairman and directorate changes
PU
More news
Financials
Sales 2020 2 769 M 3 770 M 3 770 M
Net income 2020 225 M 306 M 306 M
Net Debt 2020 743 M 1 011 M 1 011 M
P/E ratio 2020 39,8x
Yield 2020 1,79%
Capitalization 9 061 M 12 371 M 12 337 M
EV / Sales 2020 3,54x
EV / Sales 2021 3,35x
Nbr of Employees 45 653
Free-Float 99,1%
Chart INTERTEK GROUP PLC
Duration : Period :
Intertek Group plc Technical Analysis Chart | ITRK | GB0031638363 | MarketScreener
Technical analysis trends INTERTEK GROUP PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 5 932,10 GBX
Last Close Price 5 630,00 GBX
Spread / Highest target 26,1%
Spread / Average Target 5,37%
Spread / Lowest Target -27,2%
EPS Revisions
Managers and Directors
NameTitle
André Lacroix Chief Executive Officer & Executive Director
Andrew David Martin Chairman
Ross McCluskey Chief Financial Officer & Executive Director
Diane Bitzel Group Chief Information Officer
Pamela Louise Dame Makin Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
INTERTEK GROUP PLC-0.32%12 371
CINTAS CORPORATION-7.17%34 463
TELEPERFORMANCE5.64%20 412
UNITED RENTALS9.32%18 288
LG CORP.26.29%17 504
EDENRED-1.38%13 644